Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Exchange
OTC Link
OS
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $1.51B | $1.44B | $1.32B | $1.56B | $1.73B | $1.53B | $12.52B | $1.51B |
| Cost of revenue | $453.9M | $433.4M | $374.6M | $444.6M | $644.4M | $477.7M | $546.3M | $587.6M |
| Gross profit | $1.06B | $1.00B | $952.9M | $1.11B | $1.15B | $1.05B | $1.07B | $925.4M |
| Gross margin | 70.0% | 69.9% | 72.5% | 71.4% | 66.5% | 68.7% | 8.5% | 61.2% |
| R&D | $18.5M | $13.6M | $9.5M | $11.3M | $7.7M | $12.2M | $9.1M | $11.6M |
| Operating income | $696.1M | $651.0M | $669.4M | $770.4M | $811.3M | $624.2M | $573.9M | $473.5M |
| EBITDA | $751.3M | $777.4M | $769.0M | $786.6M | $876.4M | $640.6M | $722.0M | $571.8M |
| Net income | $580.8M | $558.1M | $542.4M | $607.7M | $645.1M | $4.22B | $500.1M | $397.1M |
| Net margin | 38.4% | 38.8% | 41.2% | 39.1% | 37.3% | 276.7% | 4.0% | 26.2% |
| EPS (diluted) | 0.69 | 0.67 | 0.65 | 0.73 | 0.77 | 0.65 | 4.66 | 0.47 |
Annual figures · source: Financial Modeling Prep
| Year | Est. revenue | Est. EPS | EPS range | # Analysts |
|---|---|---|---|---|
| 2026 | $1.7B | $0.59 | $0.58–$0.60 | 1 |
| 2027 | $1.9B | $0.67 | $0.66–$0.68 | 1 |
| 2028 | $2.0B | $0.86 | $0.85–$0.87 | 1 |
Forward consensus · source: Financial Modeling Prep
BEIJING TONG REN TANG
No one on the platform currently holds BJTRF.
No tracked institution reports a position in BJTRF as of their last filing.
| Ex-date | Per share | Pay date |
|---|---|---|
| 2026-06-16 | $0.0300 | 2026-06-26 |
| 2026-06-16 | $0.3700 | 2026-06-26 |
| 2025-06-09 | $0.3500 | 2025-06-18 |
| 2024-06-14 | $0.3300 | 2024-06-24 |
No one on the platform has traded BJTRF yet.
| +0.00% |
| $334M |
| — |
| FDMDF4DMedical Limited | $3.00 | +0.00% | $1.8B | — |
| FOGCFAvisa Diagnostics Inc. | $0.00 | +0.00% | $97176 | — |
Source: Financial Modeling Prep · peers by sector/industry
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.